Adverse drug reactions of GLP-1 agonists: A systematic review of case reports.
Citations
0
Subjects
Non-Human
Study Context
Systematic reviews comprehensively search, evaluate, and synthesize all available research on a specific question. They follow a rigorous, pre-defined methodology to minimize bias in the review process itself.
What This Study Type Means
- Comprehensive literature search across multiple databases
- Pre-defined inclusion and exclusion criteria reduce cherry-picking
- Quality assessment of individual studies included
- Broader and more reliable conclusions than any single study
Evidence Reliability: Very High — systematic reviews sit at the top of the evidence hierarchy
Why This Matters
This research contributes to the scientific understanding of Semaglutide. Each published study helps build the evidence base for mechanisms of action, dosing protocols, safety profiles, and therapeutic potential. Explore our comprehensive research guide for the latest findings and community insights.
How to Interpret This Research
Look for the sample size — larger studies produce more reliable results. Single-digit sample sizes warrant caution.
Check whether the study was funded by a pharmaceutical company or conducted independently, as funding sources can influence study design and reporting.
Reviews are only as good as the studies they include. Check whether the review examined study quality or simply tallied results.
Look for discussion of publication bias — studies with negative results are less likely to be published, which can skew review conclusions.
Always consult a qualified healthcare provider before making treatment decisions based on research findings. Published research is not a substitute for personalized medical advice.
Citation
Shetty Rashmi, Basheer Fathima Thashreefa, Poojari Pooja Gopal et al.. (2022). Adverse drug reactions of GLP-1 agonists: A systematic review of case reports.. Diabetes & metabolic syndrome. https://doi.org/10.1016/j.dsx.2022.102427
Related Papers
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.
Carbonless amino acids and a carbonless GHK peptide.
The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways.
Glycyl-L-histidyl-L-lysine-Cu2
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Explore Further
This content is derived from peer-reviewed research for educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide-based therapy.